Literature DB >> 24082380

Atrial myxoma in a patient with hypertrophic cardiomyopathy.

Mahmoud Abdou1, Salim Hayek, Byron R Williams.   

Abstract

Atrial myxoma is the most common primary cardiac tumor. Patients with atrial myxoma typically present with obstructive, embolic, or systemic symptoms; asymptomatic presentation is very rare. To our knowledge, isolated association of atrial myxoma with hypertrophic cardiomyopathy has been reported only once in the English-language medical literature. We report the case of an asymptomatic 71-year-old woman with known hypertrophic cardiomyopathy in whom a left atrial mass was incidentally identified on cardiac magnetic resonance images. After surgical excision of the mass and partial excision of the left atrial septum, histopathologic analysis confirmed the diagnosis of atrial myxoma. The patient was placed on preventive implantable cardioverter-defibrillator therapy and remained asymptomatic. The management of asymptomatic cardiac myxoma is a topic of debate, because no reports definitively favor either conservative or surgical measures.

Entities:  

Keywords:  Abnormalities, multiple/diagnosis; cardiomyopathy, hypertrophic/diagnosis/physiopathology; heart atria/pathology; heart neoplasms/diagnosis/pathology/surgery; myxoma/diagnosis/pathology/surgery; risk factors

Mesh:

Year:  2013        PMID: 24082380      PMCID: PMC3783132     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  8 in total

1.  Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis).

Authors:  B D Coppin; I K Temple
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

Review 2.  Clinical practice. Hypertrophic obstructive cardiomyopathy.

Authors:  Rick A Nishimura; David R Holmes
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

Review 3.  Cardiac tumours: diagnosis and management.

Authors:  Charles J Bruce
Journal:  Heart       Date:  2011-01       Impact factor: 5.994

4.  Combined apical hypertrophic cardiomyopathy and left atrial myxoma.

Authors:  N Kanemoto; N Nishiumi; H Inoue; S Koide; S Kawada; A Shotsu
Journal:  Chest       Date:  1992-04       Impact factor: 9.410

5.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.

Authors:  B J Maron; S A Casey; L C Poliac; T E Gohman; A K Almquist; D M Aeppli
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272

Review 6.  Cardiac myxomas.

Authors:  K Reynen
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies.

Authors:  K Y Lam; P Dickens; A C Chan
Journal:  Arch Pathol Lab Med       Date:  1993-10       Impact factor: 5.534

Review 8.  The management of hypertrophic cardiomyopathy.

Authors:  P Spirito; C E Seidman; W J McKenna; B J Maron
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.